Author:
Dharmarajan T. S.,Pitchumoni C. S.
Publisher
Springer International Publishing
Reference116 articles.
1. Abu-Shanab A, Quigley EM. Diagnosis of small intestinal bacterial overgrowth: the challenges persist. Expert Rev Gastroenterol Hepatol. 2009;3(1):77–87.
2. Adike A, DiBaise JK. Small intestinal bacterial overgrowth: nutritional implications, diagnosis and management. Gastroenterol Clin N Am. 2018;47(1):193–20.
3. Almeida JA, Kim R, Stoita A, et al. Lactose malabsorption in the elderly, role of small intestinal bacterial overgrowth. Scand J Gastroenterol. 2008;43:146–54.
4. Baker J, Tavakkoli A, Azeem A, et al. Factors associated with glucose hydrogen breath test positivity for intestinal bacterial overgrowth in a large cohort of diabetic patients: comparison with non-diabetics. Am J Gastroenterol. 2015;110(1):S1006–7.
5. Barkin JA, Keihanian T, Barkin JS, et al. Preferential usage of rifaximin for the treatment of hydrogen-positive small intestinal bacterial overgrowth. Rev Gastroenterol Peru. 2019;39(2):111–5.